RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
Objective: to define the clinical value of rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (anti-CCP) in early psori- atic arthritis (PA). Subjects and methods. Fifty-six patients (32 females and 24 males) with early PA with a mean duration of 12±6.7 months were studied. The...
Main Authors: | V. V. Badokin, I. A. Troshkina, E. N. Alexandrova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2011-06-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1290 |
Similar Items
-
Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
by: E N Aleksandrova, et al.
Published: (2004-12-01) -
Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
by: Pureun Won, et al.
Published: (2021-06-01) -
The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
by: Damjanovska Ljubinka, et al.
Published: (2007-01-01) -
Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis
by: Tomoya Shibahara, et al.
Published: (2016-07-01) -
The diagnostic value of anti-cyclic citrullinated peptide antibodies, adenosine deaminase activity and other potential biomarkers for predicting and monitoring rheumatoid arthritis
by: Mehanović-Nikolić Jasminka, et al.
Published: (2008-01-01)